Back

Prevalence, incidence and progression of valvular heart disease in older adults in primary care: the OxVALVE screening cohort study

31 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Aortic regurgitation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nicholas Jones

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Echocardiographic criteria at intervention in patients with chronic severe aortic regurgitation
Doctor E. Pozo Osinalde (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Deep learning for atrioventricular regurgitation diagnosis: an external validation study
Doctor I. Cohen (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Atrioventricular valve regurgitation progression after transcatheter aortic valve replacement
Doctor M. Abrantes De Figueiredo (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary stress echocardiography and outcomes in patients with moderate and severe aortic regurgitation, not fulfilling current guidelines for intervention
Doctor A. Mohamed (Eastbourne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Aortic regurgitation

The Event

Event poster

ESC Congress 2025

31 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Prospective registry of epidemiology of valve disease in asymptomatic italian elderly subjects
thumbnail
Congress Presentation
Prevalence of multiple native valvular heart disease in TAVR patients: a multicenter study assessing the impact of staged transcatheter edge-to-edge repair
thumbnail
Congress Presentation
Frequency, course and prognostic yield of valvular heart disease in the general population- Results from the STAAB cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources